TickerTalks
Browse all tickers →
TickerTalks›$BTI
BTBTI

British American Tobacco p.l.c.

$BTI·$120B·Tobacco·Consumer Defensive
$55.83-0.3%YTD-1.0%1Y+1.7%
Price updated 9h ago·X counts updated 6d ago
BTBTI
$BTIBritish American Tobacco p.l.c.
$55.83-0.34%109 posts1×
AI analysisFundamentalsVoices on X
Loading…

On X

The complete picture of $BTI on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.

109X posts · last 7 days
Sep 2Sep 14
Chatter Meter
1×
QuietNormal · 1×Loud

How loud $BTI's conversation on X is versus its own normal — 1× is typical, higher means busier. Right now it's about its usual level, louder than 55% of tracked names.

Neutral sentimentAI analysisGenerated by AI from underlying data8 posts analyzed · as of 2026-09-10

British American Tobacco chatter is a mix of product news (VUSE Pro US launch with mandatory age verification even without FDA authorization) and macro musings comparing tobacco's cash-extraction model to AI's capital-hunger. Traders note it's dead money but paying dividends and awaiting seasonality. No strong direction.

Read what X is saying about $BTI

  • Bullish vs bearish call — with the AI summary of the day's posts
  • Divergence flag when the top-engagement posts argue the other side
  • How loud the conversation is versus this ticker's own normal
Free, forever. No credit card.

AI verdictAI analysisGenerated by AI from underlying data

TickerTalks' own read on what's driving $BTI — fundamentals, momentum, or an event — and whether it agrees with the X crowd.

Proven numbersStalledAI verdict · as of 2026-09-19

The move has stalled — likely just drifts unless something new shows up.

BAT the classic tobacco-yield trade — dead money paying dividends while the smoke-free pivot slowly plays out.

British American Tobacco is the global tobacco leader plus a smoke-free portfolio — Vuse (vapor), Velo (nicotine pouches), and glo (heated products). The ADR is essentially flat over 12 months and trades as a yield-plus-transition story.

  • The operating economics are stable: revenue essentially flat YoY (-0.1%) at $12.3B, operating margin at 38%, and consecutive small EPS beats (+1.8% and +2%) — this is what a mature tobacco compounder looks like when the cigarette base is declining but the smoke-free mix is stabilizing revenue.
  • The valuation is where deep-value tobacco lives: 15x TTM earnings, 5.7% FCF yield with a substantial dividend, and 0.08x debt-to-equity — the balance sheet is fortress-quality, and the yield is what carries most of the total-return case.
  • The Vuse Pro US launch is a specific new-product catalyst: the mandatory age verification even without FDA authorization is a competitive-positioning move ahead of the US regulatory-decision cycle — this is the kind of specific product tape that historically drives modest tobacco outperformance.

Next catalyst is the Feb 11 full-year print, so this is essentially a yield trade until then. The 'dead money paying dividends and awaiting seasonality' framing captures it — this is not a compounder that will re-rate on a beat, it's a defensive-yield allocation. Watch $54 as trend support; a break there would signal specific fundamental deterioration rather than the range-bound tape this has been.

Agrees with X sentimentThe 'dead money paying dividends' framing is honest and captures the actual setup. The Vuse Pro launch is a real product event but not a rerating catalyst; the tobacco/AI-capital contrast is philosophical, not directional.

What to watch: Feb 11 2027 full-year earnings — smoke-free revenue growth, US FDA correspondence on Vuse Pro, and dividend framework. Watch $54 as trend support.

On the calendar: 2027-02-11 — Full-year earnings

Read the AI verdict on $BTI

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • Whether TickerTalks' read agrees with or diverges from the X crowd
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Global tobacco group selling cigarettes, vapor products, heated tobacco, and nicotine pouches across 180+ markets under Camel, Lucky Strike, and Vuse.

Industry overviewAI analysisGenerated by AI from underlying data

Where Tobacco sits in its cycle right now — and what that implies for $BTI.

Tobacco · Consumer Defensive

Oral nicotine pouches (ZYN, Velo) and heated tobacco (IQOS, glo) are the growth offsets to structural combustible volume decline; PM's ZYN can expansion signals smoke-free category pricing confidence, while BTI's unauthorized flavored Vuse rollout introduces near-term FDA enforcement risk against an otherwise dividend-stable sector.

What this means for $BTI

Partial — BAT's Vuse vapor and Velo nicotine pouches are active next-gen products capturing smoke-free share; unauthorized flavored Vuse rollout without FDA marketing authorization introduces near-term enforcement and brand risk alongside the smoke-free transition tailwind.

Industry benchmark

4-name peer basket
+5.3%YTD
-12.9%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
15.0How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
7.6%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
37.6%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
5.7%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
3.7Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
13.4%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
60.2%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.1Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 30, 2026$2.25$2.21+1.8%
Q4 2025Feb 12, 2026$2.55$2.50+2.0%
Q2 2025Jul 31, 2025$2.79$2.24+24.6%
Q4 2024Feb 13, 2025$2.50$2.44+2.5%
Next earningsThu, Feb 11·consensus EPS $2.64

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$12.3B-0.1%59.1%38.2%$1.47$2.5B
Q4 FY25$13.5B-2.2%83.4%36.4%$1.45$3.6B
Q2 FY25$12.1B-10.2%83.6%42.0%$2.05$2.2B
Q4 FY24$13.5B-8.5%83.2%-11.3%$-0.66$6.5B

Forward consensus

5-year forecast · up to 9 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$26.2B$25.8B – $26.4B$3.61$3.57 – $3.658
FY27$27.1B$26.8B – $27.3B$3.88$3.82 – $3.959
FY28$28.1B$27.8B – $28.5B$4.20$4.14 – $4.263
FY29$29.5B$29.2B – $29.9B$4.60$4.53 – $4.674
FY30$32.1B$31.7B – $32.5B$5.30$5.23 – $5.384

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.6×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.34%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-3.8%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-5.6%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatMega float · 2.2B shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.1% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.135-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

No material 8-K / SC 13D / S-3 / 424B5 filings in the last 180 days.

+ 51 other (43 6-Ks · 2 25-NSEs · 2 13Gs · 1 CERT) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

British American Tobacco set for faster growth as smokeless bet pays off, says Jefferiesproactiveinvestors.com·2d ago4 Tobacco Stocks Turning Huge Cash Flow Into High-Yield Dividends247wallst.com·2d ago4 High-Yield Dividend Stocks to Own for the Next Decadefool.com·4d agoBritish American Tobacco vs Altria: Which High-Yield Dividend Stock Is the Better Buy247wallst.com·4d agoZacks Industry Outlook Philip Morris, British American Tobacco and Altriazacks.com·6d ago

More in Tobacco

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$PM$MO$RYM$RLX
Voices on X · last 7 days

No standout posts about $BTI on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport